Akin advised Pharmakon Advisors on the deal. Pharmakon Advisors, LP, a leading investor in non-dilutive debt for the life sciences industry, announced its $450 million financing commitment...
You must be a Standard 1 Year member to access this content.
Fenwick advised Pharmakon on the deal while Akin Gump advised Pharmakon Advisors. Pharmakon, an investor in non-dilutive debt for the life sciences industry and the investment...
You must be a Standard 1 Year member to access this content.
Akin Gump Strauss Hauer & Feld LLP advised BioPharma Credit PLC on the deal, while Dechert LLP advised Pharmakon Advisors LP. LumiraDx has secured new financing commitments...
You must be a Standard 1 Year member to access this content.
